Josep Cucurull

Improvement of Mitochondrial Toxicity in Patients Receiving a Nucleoside Reverse‐Transcriptase Inhibitor–Sparing Strategy: Results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA)

Eugènia Negredo, Òscar Miró, Benjamí Rodríguez‐Santiago et al. · Clinical Infectious Diseases · 2009 · 46 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Long-Term Safety and Efficacy of Nevirapine-Based Approaches in HIV Type 1-Infected Patients

Anna Bonjoch, Roger Paredes, Peré Domingo et al. · AIDS Research and Human Retroviruses · 2006 · 42 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients

Jordi Navarro, Montserrat Laguno, Helem Vílchez et al. · Journal of Antimicrobial Chemotherapy · 2017 · 17 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection

Juan A. Pineda, Luís Morano, Rafael Granados et al. · Clinical Microbiology and Infection · 2017 · 12 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16